[go: up one dir, main page]

BRPI0511421A - cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process - Google Patents

cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process

Info

Publication number
BRPI0511421A
BRPI0511421A BRPI0511421-7A BRPI0511421A BRPI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A
Authority
BR
Brazil
Prior art keywords
keratin
cosmetic
compositions
containing materials
effector molecule
Prior art date
Application number
BRPI0511421-7A
Other languages
Portuguese (pt)
Inventor
Heiko Barg
Thomas Subkowski
Hans-Georg Lemaire
Claus Bollschweiler
Arne Ptock
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025805 external-priority patent/DE102004025805A1/en
Priority claimed from DE200510011988 external-priority patent/DE102005011988A1/en
Application filed by Basf Ag filed Critical Basf Ag
Publication of BRPI0511421A publication Critical patent/BRPI0511421A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to novel keratin-binding protein active substances, and also to the production and use thereof. Particularly suitable keratin-binding polypeptides are sequences which are contained in human desmoplakin or are derived therefrom by altering the human desmoplakin polypeptide sequences such as amino acid insertions, substitutions or deletions. The polypeptide sequences of the human desmoplakin is represented in SEQ ID NO: 1. A suitable keratin-binding domain (domain B) is the polypeptide sequence SEQ ID NO: 1, position 2193 2481, in addition to functional equivalents thereof. An additional keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO: 1, position 2606 2871 and the functional equivalents thereof.
BRPI0511421-7A 2004-05-24 2005-05-24 cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process BRPI0511421A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE200410025805 DE102004025805A1 (en) 2004-05-24 2004-05-24 Cosmetic compound for incorporation in pharmaceutical products for treatment of e.g. human skin, hair and nails
DE200510011988 DE102005011988A1 (en) 2005-03-14 2005-03-14 The present invention relates to the use of keratin-binding polypeptides and their preparation
PCT/EP2005/005599 WO2005115306A2 (en) 2004-05-24 2005-05-24 Keratin-binding polypeptides

Publications (1)

Publication Number Publication Date
BRPI0511421A true BRPI0511421A (en) 2008-01-29

Family

ID=35134164

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511421-7A BRPI0511421A (en) 2004-05-24 2005-05-24 cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process

Country Status (13)

Country Link
US (1) US20080075684A1 (en)
EP (1) EP1763334B1 (en)
JP (1) JP2008500301A (en)
AT (1) ATE417595T1 (en)
AU (1) AU2005247092B2 (en)
BR (1) BRPI0511421A (en)
CA (1) CA2563999A1 (en)
DE (1) DE502005006284D1 (en)
ES (1) ES2317237T3 (en)
MX (1) MXPA06013458A (en)
NZ (1) NZ551366A (en)
RU (1) RU2411029C2 (en)
WO (1) WO2005115306A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP2371362B1 (en) 2004-01-22 2020-07-01 University of Miami Co-enzyme Q10 formulations for treating solid tumours by intravenous administration
US7892788B2 (en) 2005-02-07 2011-02-22 Basf Se Hydrophobin fusion products, production and use thereof
EP1866150B1 (en) 2005-03-31 2016-10-19 Basf Se Metallic substrates having polypeptides as adhesive agents
MX270311B (en) 2005-04-01 2009-09-23 Basf Ag Drilling fluid containing hydrophobin.
US8535535B2 (en) 2005-04-01 2013-09-17 Basf Se Use of hydrophobin as a phase stabilizer
DE102005027139A1 (en) 2005-06-10 2006-12-28 Basf Ag New cysteine-depleted hydrophobin fusion proteins, their production and use
DE102005029704A1 (en) * 2005-06-24 2007-01-11 Basf Ag Use of hydrophobin polypeptides and conjugates of hydrophobin polypeptides with active or effect substances and their preparation and their use in cosmetics
DE102005048720A1 (en) 2005-10-12 2007-04-19 Basf Ag Use of proteins as an antifoam component in fuels
US20090099075A1 (en) * 2005-11-24 2009-04-16 Basf Se Chimeric Keratin-Binding Effector Proteins
CA2630903A1 (en) * 2005-11-24 2007-12-27 Basf Se Keratin-binding effector molecules, and method for the production thereof
EP1968642A2 (en) * 2005-11-24 2008-09-17 Basf Se Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups
US20090098074A1 (en) * 2005-12-01 2009-04-16 Basf Se Keratin-Binding Effector Molecules Containing Reactive Dyes
WO2008019965A1 (en) 2006-08-15 2008-02-21 Basf Se Method for the production of dry free-flowing hydrophobin preparations
US20080280810A1 (en) * 2006-10-30 2008-11-13 O'brien John P Peptides having affinity for body surfaces
US20080175798A1 (en) * 2006-12-11 2008-07-24 Beck William A Peptide-based hair protectants
MX352434B (en) 2007-03-22 2017-11-24 Berg Llc Topical formulations having enhanced bioavailability.
DE102007058845A1 (en) * 2007-12-05 2009-06-10 Henkel Ag & Co. Kgaa Hair cleanser with surfactant / thickener combination
US20110136231A1 (en) 2008-04-11 2011-06-09 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
FR2932087B1 (en) * 2008-06-10 2012-10-12 Oreal COSMETIC USE OF DESMOPLAKINE-LIKE PROTEINS FOR THE TREATMENT OF SKIN DROUGHT
US8697654B2 (en) 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158822A1 (en) * 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
JP5903735B2 (en) 2009-05-11 2016-04-13 バーグ エルエルシー Method of treating diseases using epimetabolic shifter (Coenzyme Q10)
EA032941B1 (en) 2010-03-12 2019-08-30 БЕРГ ЭлЭлСи INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND USE THEREOF
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
US10973763B2 (en) 2011-06-17 2021-04-13 Berg Llc Inhalable pharmaceutical compositions
US9745543B2 (en) 2012-09-10 2017-08-29 Ecolab Usa Inc. Stable liquid manual dishwashing compositions containing enzymes
US9622951B2 (en) 2012-10-29 2017-04-18 The Procter & Gamble Company Personal care compositions
CN105338973A (en) 2013-04-08 2016-02-17 博格有限责任公司 Treatment of cancer using coenzyme q10 combination therapies
DE102013213170A1 (en) 2013-07-04 2015-01-08 Beiersdorf Ag Octocrylene-free, odor-stable sunscreen
US9672952B2 (en) 2013-08-14 2017-06-06 Industrial Technology Research Institute Polymer and conductive composition
ES2825083T3 (en) 2013-09-04 2021-05-14 Berg Llc Cancer Treatment Methods Using Continuous Coenzyme Q10 Infusion
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
BR112020019944A2 (en) * 2018-04-13 2021-01-26 Massachusetts Institute Of Technology modified treatments for hair repair and lasting color retention
WO2021245018A1 (en) 2020-06-02 2021-12-09 Unilever Ip Holdings B.V. A high spf skin cleansing composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3867710D1 (en) * 1987-06-01 1992-02-27 Keikichi Sugiyama COMPOSITION FOR APPLICATION ON HAIR AND SCALP.
JP2748174B2 (en) * 1990-01-29 1998-05-06 株式会社成和化成 Cosmetic base
DE69313891T2 (en) * 1992-02-20 1998-05-07 Sumitomo Electric Industries Process for connecting superconducting wires made of oxide high-temperature superconductors
GB9217444D0 (en) * 1992-08-17 1992-09-30 Unilever Plc Compounds compositions and methods for producing pigmentation in hair or skin
DE69310339T2 (en) * 1993-02-19 1997-08-21 Philippe Djian Preparations that contain corneocyte proteins
JP3446980B2 (en) * 1994-12-08 2003-09-16 株式会社成和化成 Hair cosmetics
DE19626762A1 (en) * 1996-07-03 1998-01-08 Basf Ag Enzymatically cleavable linker for solid phase synthesis
JP2000281539A (en) * 1999-01-29 2000-10-10 Seiwa Kasei:Kk Cosmetic base
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JPWO2003042387A1 (en) * 2001-11-13 2005-03-10 学校法人慶應義塾 Novel hair keratin-associated protein
WO2004048938A2 (en) * 2002-11-26 2004-06-10 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators

Also Published As

Publication number Publication date
WO2005115306A2 (en) 2005-12-08
US20080075684A1 (en) 2008-03-27
NZ551366A (en) 2009-01-31
RU2411029C9 (en) 2011-10-20
MXPA06013458A (en) 2007-03-01
AU2005247092A1 (en) 2005-12-08
ES2317237T3 (en) 2009-04-16
DE502005006284D1 (en) 2009-01-29
RU2411029C2 (en) 2011-10-20
ATE417595T1 (en) 2009-01-15
EP1763334B1 (en) 2008-12-17
EP1763334A2 (en) 2007-03-21
RU2006145670A (en) 2008-06-27
WO2005115306A3 (en) 2006-03-16
AU2005247092B2 (en) 2010-01-07
CA2563999A1 (en) 2005-12-08
JP2008500301A (en) 2008-01-10

Similar Documents

Publication Publication Date Title
BRPI0511421A (en) cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process
Dekan et al. Total synthesis of human hepcidin through regioselective disulfide‐bond formation by using the safety‐catch cysteine protecting group 4, 4′‐dimethylsulfinylbenzhydryl
BRPI0409924A (en) substituted amino carboxylic acids
UA103154C2 (en) Hla-a*-1101-restricted wt1 peptide and pharmaceutical composition comprising thereof
EA200802396A1 (en) IMPROVED sgp130Fc dimers
BRPI0411172A (en) peptide, peptide dimer, its use and pharmaceutical composition
EA200800368A1 (en) GLYCOSILIZED IL-7, PRODUCTION AND USE
BRPI0413728B8 (en) human tear lipocalin mutein, methods for generating and producing mutein, pharmaceutical composition and use of mutein
Sivanesam et al. Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin‐binding geometry hypothesis
ATE506957T1 (en) PROPHYLACTIC/THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES
KR20190101990A (en) Composition comprising the peptide WKDEAGKPLVK
KR102077983B1 (en) Composition for improving skin wrinkles and skin whitening
DE69900756D1 (en) USE OF HMG PROTEINS FOR THE PRODUCTION OF MEDICINAL PRODUCTS WITH CYTOTOXIC EFFECT
WO2006097432A3 (en) Keratin-binding desmoplakin polypeptide sequences
EA201100459A1 (en) COMPOSITIONS INCLUDING INTERLEUKIN-1 AND PEPTIDES
KR102093093B1 (en) Composition for improving skin anti-aging
Kim et al. Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
ATE532502T1 (en) COSMETIC COMPOSITION FOR HAIR
Gowd et al. Dissecting a role of evolutionary‐conserved but noncritical disulfide bridges in cysteine‐rich peptides using ω‐conotoxin GVIA and its selenocysteine analogs
BR122018077204B8 (en) human heat stress protein peptides, pharmaceutical composition, and, use of the peptide and pharmaceutical composition
DK1947175T3 (en) Sequence of nucleotides and peptides GSE 24.2 of dyskerin capable of inducing telomerase activity, process for its preparation, therapeutic compositions and uses thereof
ITRM20020277A1 (en) TYPE 1 PLACENTAR GROWTH FACTOR MUTEINE, PREPARATION METHOD AND THEIR APPLICATIONS.
KR20080030031A (en) Hair vitality and elasticity improver and hair cosmetic
JP5827958B2 (en) Novel caspase-14 activating peptide and composition containing the same

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.